Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02488629
What this trial is testing

Study of SCB01A in Patient With Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
SynCore Biotechnology Co., Ltd. 5
Testing effectiveness (Phase 2)Study completedNCT04220866
What this trial is testing

Study of Intratumoral (IT) Ulevostinag (MK-1454) in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Merck Sharp & Dohme LLC 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07840456
What this trial is testing

Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck HNSCC
University Hospital, Basel, Switzerland 66
Testing effectiveness (Phase 2)Study completedNCT01289522
What this trial is testing

Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Head and Neck CarcinomaRecurrent or Metastatic Disease
Groupe Oncologie Radiotherapie Tete et Cou 54
Testing effectiveness (Phase 2)Study completedNCT01040832
What this trial is testing

EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck Cancer
EMD Serono 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT05280457
What this trial is testing

HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Yonsei University 21
Not applicableActive Not RecruitingNCT05931445
What this trial is testing

Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer

Who this might be right for
Breast CancerLung CancerColorectal Cancer+5 more
Comprehensive Support Project for Oncology Research 500
Not applicableStudy completedNCT02543476
What this trial is testing

SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 412
Testing effectiveness (Phase 2)Active Not RecruitingNCT04862650
What this trial is testing

Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+22 more
Marcelo Bonomi
Not applicableLooking for participantsNCT07448727
What this trial is testing

Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT

Who this might be right for
Head & Neck CancerHead & Neck Squamous Cell Carcinoma
University of Rome Tor Vergata 25
Testing effectiveness (Phase 2)Ended earlyNCT00062387
What this trial is testing

Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT02123511
What this trial is testing

Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

Who this might be right for
MucositisOral ComplicationsRecurrent Adenoid Cystic Carcinoma of the Oral Cavity+80 more
Mayo Clinic 34
Early research (Phase 1)Ended earlyNCT03525392
What this trial is testing

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerGastric Cancer+5 more
Ipsen 14
Testing effectiveness (Phase 2)UnknownNCT05027204
What this trial is testing

Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 94
Testing effectiveness (Phase 2)Study completedNCT01816984
What this trial is testing

PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+33 more
University of Chicago 12
Testing effectiveness (Phase 2)Study completedNCT02319044
What this trial is testing

Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck
AstraZeneca 267
Large-scale testing (Phase 3)Study completedNCT00401323
What this trial is testing

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck NeoplasmsNeoplasm Recurrence, LocalNeoplasm Metastasis
Sanofi 568
Large-scale testing (Phase 3)Study completedNCT02369874
What this trial is testing

Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer

Who this might be right for
Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN
AstraZeneca 736
Testing effectiveness (Phase 2)Looking for participantsNCT07136545
What this trial is testing

A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)

Who this might be right for
HNSCC
Taipei Veterans General Hospital, Taiwan 50
Testing effectiveness (Phase 2)Looking for participantsNCT06494995
What this trial is testing

AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fudan University 52
Next Page
46